This year’s ASTRO Annual Meeting is being held October 1-4, in San Diego. The meeting theme, “Pay it Forward: Partnering with Our Patients,” is instilled throughout the programming. This meeting features an engaging program with the latest breaking research presented in scientific and education sessions along with dynamic networking events.
We look forward to seeing you in San Diego for the 2023 ASTRO Annual Meeting! Please join our UT Southwestern faculty for over 30 innovative scientific sessions, poster Q&A, and panel sessions
You can search and find all events of the meeting here:
Saturday, September 30
Education Session – PRO: Treatment and Management of Larynx Cancer
Early Stage Larynx Cancer
Speaker: D Sher
Time: 11:02 a.m.
Education Session – ARRO Annual Seminar
Mixtroz Mentorship Meet & Greet
Speaker: M Arbab
Time: 12:21 p.m.
Education Session – 2023 ASTRO-ARRO Medical Student Workshop
Rad Onc Research While in Medical School
Speaker: M Arbab
Time: 1:30 p.m.
Education Session – ARRO Annual Seminar
Job Panel – Academic
Speaker: M Arbab
Time: 2:49 p.m.
Sunday, October 1
Special Session – 2023 Aspiring Scientists and Physicians Program for Underrepresented in Medicine – Concurrent Breakout
Session: International Panel
Speaker: M Arbab
Time: 12:15 p.m.
Poster Q&A – Lung Cancer and DEIH
Dosimetric Analysis of CBCT-Based Weekly Online Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Authors: R Li, S Montalvo, D Parsons, B Hrycushko, H Kim, L Chen, X Zhong, Z Iqbal, K Westover, Y Zhang, R Timmerman, T Zhuang, B Cai, M Lin, and P Iyengar
Time: 4:45 p.m.
Poster Q&A – Lung Cancer and DEIH
Predictive Factors for Response to Adaptive Therapy in Thoracic Stereotactic Ablative Radiotherapy
Authors: S Montalvo, M Arbab, M Aliru, C Shen, Y Gonzalez, M Lin, D Parsons, T Zhuang, B Cai, A Pompos, R Hannan, K Westover, Y Zhang, R Timmerman, and P Iyengar
Time: 4:45 p.m.
Poster Q&A – Lung Cancer and DEIH
Could Poor Outcomes for Patients with Limited Lung Function Treated with SAbR Necessitate PULSAR™
Authors: M Aliru, Y Zhang, K Westover, R Timmerman, and P Iyengar
Time: 4:45 p.m.
Education Session – Adaptive Radiotherapy Workflow and Models of Care
Physician Considerations in Adaptive Workflows and Models of Care
Speaker: D Sher
Time: 5:17 p.m.
Monday, October 2
Scientific Session – Experimental Therapeutics and Molecular Imaging
Combination of BET Inhibition with Radiation Induces Anti-Tumor Immune Response in Pre-Clinical Models of ER-Positive Breast Cancer
Authors: C Vidal, M Arbab, A Rahimi, and P Alluri
Time: 3 p.m.
Poster Q&A – Breast Cancer and Nonmalignant Disease
A Comprehensive Deep Learning Framework for Automatic Target Volumes Segmentation in Post-Operative Stereotactic Partial Breast Irradiation (S-PBI)
Authors: M Kazemimoghadam, Z Yang, M Chen, A Rahimi, N Kim, P Alluri, C Nwachukwu, W Lu, and X Gu
Time: 3 p.m.
Poster Q&A – Breast Cancer and Nonmalignant Disease
Racial Difference in Outcomes in Breast Cancer Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy
Authors: C Johns, Y Kwon, A Rahimi, Y Liu, M Cauble, P Alluri, M Arbab, C Nwachukwu, and N Kim
Time: 3 p.m.
Poster Q&A – Breast Cancer and Nonmalignant Disease
Multi-Institutional Phase II Trial Using Dose Escalated Five Fraction Stereotactic Partial Breast Irradiation (S-PBI) with GammaPodTM for Early Stage Breast Cancer
Authors: A Rahimi, N Kim, M Leitch, E Nichols, X Gu, D Parsons, W Lu, S Becker, P Alluri, C Nwachukwu, C Ahn, Y Zhang, A Spangler, D Farr, R Wooldridge, S Bahrami, S Stojadinovic, M Lieberman, S Neufeld, and R Timmerman
Time: 3 p.m.
Poster Q&A – Breast Cancer and Nonmalignant Disease
Five-Fraction Stereotactic Radiation for Head-and-Neck Paragangliomas
Authors: D Keilty, B Isaacson, V Avkshtol, W Kutz, D Moon, J Hunter, T Dan, D Vo, S Barnett, D Sher, and Z Wardak
Time: 3 p.m.
Poster Q&A – Breast Cancer and Nonmalignant Disease
Observed and Predicted Toxicity in Daily Cone-Beam CT-Based Online Adaptive Stereotactic Partial Breast Irradiation and Decreased PTV Margins
Authors: D Keilty, S Wang, J Visak, M Lin, L Chen, M Arbab, N Kim, P Alluri, D Parsons, and A Rahimi
Time: 3 p.m.
Poster Q&A – Breast Cancer and Nonmalignant Disease
Predicted Toxicity in Daily Cone-Beam CT-Based Online Adaptive Stereotactic Partial Breast Irradiation and Decreased PTV Margins
Authors: D Keilty, S Wang, J Visak, M Lin, L Chen, M Arbab, N Kim, P Alluri, D Parsons, and A Rahimi
Time: 3 p.m.
Scientific Session – Experimental Therapeutics and Molecular Imaging
Targeting Non-Kinase Function of CDL6 to Overcome CDK4/6 Inhibitor Resistance
Authors: P Alluri and K Udden
Time: 3:40 p.m.
Poster Q&A – Biology and PRO
Financial Toxicity and Patient Reported Outcomes on a Multi-Institutional Phase I Single Fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer
Authors: A Simmons, D Sher, N Kim, M Leitch, J Haas, X Gu, C Ahn, A Gao, A Spangler, H Morgan, D Farr, R Wooldridge, S Seiler, S Goudreau, S Bahrami, S Neufeld, C Mendez, M Lieberman, R Timmerman, and A Rahimi
Time: 5 p.m.
Poster Q&A – Biology and PRO
Tracking Changes in Global Longitudinal Strain in Lung Cancer Patients Receiving Thoracic Radiation
Authors: S Montalvo, E Kakadiaris, B Lue, M Aliru, E Zhang-Velten, W Lu, K Westover, P Iyengar, R Timmerman, V Zaha, S Vallabhaneni, K Zhang, A Chandra, and P Alluri
Time: 5 p.m.
Scientific Session – Supercharged CAR T Cell Therapy: When, Where, and How Hard to Strike with Radiation for Lymphomas
Phase I Trial of Re-Priming Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Authors: K Kumar, R Ravella, P Ramakrishnan Geethakumari, F Awan, T Aguilera, X Li, O Öz, A Kandathil, W Chen, F Fuda, C Ahn, P Iyengar, N Desai, and R Timmerman
Time: 5:10 p.m.
Scientific Session – Motion Monitoring and Deep Learning
Principal Component Analysis to Design Planning Target Volume in Oropharyngeal Cancers
Authors: M Arbab, Z Yu, Q Ge, and M Langer
Time: 5:20 p.m.
Tuesday, October 3
Panel Session – Multidisciplinary Patient-Based Approach to Challenging Situations with Cervix Cancer
Moderator: K Albuquerque
Time: 8 a.m.
Quick Pitch Session – Motion and Imaging
Real-Time 3D Liver Tumor Localization via Combined Optical Surface Imaging and an X-Ray Projection from Arbitrary Imaging Angles
Authors: H Shao, Y Li, J Wang, S Jiang, and Y Zhang
Time: 8:05 a.m.
Panel Session – Multidisciplinary Patient-Based Approach to Challenging Situations with Cervix Cancer
Ablative Radiation Therapy in Oligometastatic Cervix Cancer (OMCC): When, How, Why?/Q&A
Speaker: K Albuquerque
Time: 8:36 a.m.
Poster Q&A – Gastrointestinal Cancer and Sarcoma
Post-Progression Survival in Patients with Oligometastatic or Polymetastatic Pancreatic Adenocarcinoma
Authors: A Elamir, N Sanford, P Polanco, M Porembka, S Mutar, S Kazmi, S Beg, R Timmerman, H Zeh, and T Aguilera
Time: 12:45 p.m.
Special Session: Late Breaking Abstracts
Acute Toxicity and Efficiency Outcomes in the DARTBOARD Randomized Trial of Daily Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma
Authors: D Sher, D Moon, V Avkshtol, M Lin, R Hughes, M Dohopolski, C Liao
Time: 2:30 p.m.
Poster Q&A 06 – Genitourinary Cancer, Patient Safety, and Nursing
Long-Term Safety and Efficacy of SAbR for Metastatic RCC
Authors: D Keilty, L Zhao, M Levesque, M Stein, A Christie, A Garant, J Brugarolas, R Timmerman, and R Hannan
Time: 2:30 p.m.
Scientific Session – Special Session: Late Breaking Abstracts
Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer
Authors: A Rahimi
Time: 3 p.m.
Poster Q&A – Hematologic Malignancies and Digital Health Innovation
Cardiac Sparing with Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (CS VMAT-TBI)
Authors: S Montalvo, R Revali, N Desai, D Parsons, and K Kumar
Time: 4 p.m.
Poster Q&A – Hematologic Malignancies and Digital Health Innovation
Intelligent Interactive Deformable Image Registration for Online Adaptive Radiotherapy
Authors: T Bai, M Dohopolski, W Lu, M Lin, D Nguyen, and S Jiang
Time: 4 p.m.
Education Session – Oligometastatic Breast Cancer: Considering Patients One by One
Oligometastatic Breast Cancer: A Primer on How-To
Speaker: A Rahimi
Time: 4:32 p.m.
Poster Q&A – Gynecological Cancer, Pediatric Cancer, and Professional Development
The Changing Profile of Academic Radiation Oncology Leaders: Updates Over the Past Decade
Authors: Y Kwon, M Stein, E Hsu, A Rahimi, M Arbab, C Nwachukwu, R Timmerman, and K Kumar
Time: 5:15 p.m.